In silico analyses of pan-squamous cell carcinoma unveiled the immunological implications of MRPL13, which had previously been under-recognized

The involvement of the mitochondrial ribosomal protein 13 (MRPL13) gene in the development of adenocarcinoma has been previously reported. However, the clinicopathological significance of MRPL13 in squamous cell carcinoma (SCC) remains poorly understood. To gain insight into the clinicopathological...

Full description

Bibliographic Details
Main Authors: Yan Liang, Shuo He, Yiyi Tan, Qing Liu, Feng Zhao, Tao Liu, Conggai Huang, Xiaomei Lu, Shutao Zheng
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023107900
_version_ 1797336955670757376
author Yan Liang
Shuo He
Yiyi Tan
Qing Liu
Feng Zhao
Tao Liu
Conggai Huang
Xiaomei Lu
Shutao Zheng
author_facet Yan Liang
Shuo He
Yiyi Tan
Qing Liu
Feng Zhao
Tao Liu
Conggai Huang
Xiaomei Lu
Shutao Zheng
author_sort Yan Liang
collection DOAJ
description The involvement of the mitochondrial ribosomal protein 13 (MRPL13) gene in the development of adenocarcinoma has been previously reported. However, the clinicopathological significance of MRPL13 in squamous cell carcinoma (SCC) remains poorly understood. To gain insight into the clinicopathological and immunological implications of MRPL13 expression in SCC, we conducted a bioinformatic analysis utilizing various available databases, including TIMER 2.0, Xiantao academic tool and TISIDB, attempting to evaluate the abnormal expression, prognosis and immunological correlation of MRPL13 in the pan-SCC setting. Subsequently, we conducted experimental verification using an esophageal squamous cell carcinoma (ESCC) tissue array subjected to multiplexed immunofluorescent (mIF) staining. The ESCC tissue array we used consists of 93 dots of ESCC and 86 dots of matched adjacent normal tissues (ANT). Data from in silico analyses showed that MRPL13 mRNA is significantly up-regulated and correlated with infiltration of CD8+ T cells in pan-SCC. However, in silico analyses did not support the prognostic role of MRPL13 in SCC. Consistently, data from the ESCC tissue array showed that MRPL13 was remarkably elevated in ESCC tissues relative to ANT in stroma, which was controlled by pan-cytokeratin (pan-CK) staining. In the epithelia, no significant difference was identified between ESCC and ANT. Furthermore, MRPL13 expression markedly correlated with the infiltration of CD8+ T cells in the stromal region but not in the epithelial region. Prognostically, no significant association was observed between MRPL13 expression and overall survival, regardless of epithelial or stromal section. Through these pan-SCC analyses, we have expanded the understanding of MRPL13 previously reported, in particular, underscoring the immunological involvement of MRPL13 in the tumor microenvironment of SCC that has been under-recognized before, suggesting that MRPL13 may regulate the infiltration of CD8+ T cells into the SCC microenvironment.
first_indexed 2024-03-08T09:02:22Z
format Article
id doaj.art-46aca38fe7764790ac75cb8ba9227e5d
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-03-08T09:02:22Z
publishDate 2024-01-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-46aca38fe7764790ac75cb8ba9227e5d2024-02-01T06:32:31ZengElsevierHeliyon2405-84402024-01-01101e23582In silico analyses of pan-squamous cell carcinoma unveiled the immunological implications of MRPL13, which had previously been under-recognizedYan Liang0Shuo He1Yiyi Tan2Qing Liu3Feng Zhao4Tao Liu5Conggai Huang6Xiaomei Lu7Shutao Zheng8Department of Pathology, Basic Medicine College, Xinjiang Medical University, Urumqi, 830017, ChinaDepartment of Pathology, Basic Medicine College, Xinjiang Medical University, Urumqi, 830017, ChinaState Key Laboratory of Pathogenesis, Prevention, Treatment of Central Asian High Incidence Diseases, Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, ChinaState Key Laboratory of Pathogenesis, Prevention, Treatment of Central Asian High Incidence Diseases, Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, ChinaState Key Laboratory of Pathogenesis, Prevention, Treatment of Central Asian High Incidence Disease, Operation Management Department, First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, ChinaDepartment of Clinical Laboratory, First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, ChinaDepartment of Pathology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, ChinaState Key Laboratory of Pathogenesis, Prevention, Treatment of Central Asian High Incidence Diseases, Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, China; Corresponding author.State Key Laboratory of Pathogenesis, Prevention, Treatment of Central Asian High Incidence Diseases, Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, China; Corresponding author.The involvement of the mitochondrial ribosomal protein 13 (MRPL13) gene in the development of adenocarcinoma has been previously reported. However, the clinicopathological significance of MRPL13 in squamous cell carcinoma (SCC) remains poorly understood. To gain insight into the clinicopathological and immunological implications of MRPL13 expression in SCC, we conducted a bioinformatic analysis utilizing various available databases, including TIMER 2.0, Xiantao academic tool and TISIDB, attempting to evaluate the abnormal expression, prognosis and immunological correlation of MRPL13 in the pan-SCC setting. Subsequently, we conducted experimental verification using an esophageal squamous cell carcinoma (ESCC) tissue array subjected to multiplexed immunofluorescent (mIF) staining. The ESCC tissue array we used consists of 93 dots of ESCC and 86 dots of matched adjacent normal tissues (ANT). Data from in silico analyses showed that MRPL13 mRNA is significantly up-regulated and correlated with infiltration of CD8+ T cells in pan-SCC. However, in silico analyses did not support the prognostic role of MRPL13 in SCC. Consistently, data from the ESCC tissue array showed that MRPL13 was remarkably elevated in ESCC tissues relative to ANT in stroma, which was controlled by pan-cytokeratin (pan-CK) staining. In the epithelia, no significant difference was identified between ESCC and ANT. Furthermore, MRPL13 expression markedly correlated with the infiltration of CD8+ T cells in the stromal region but not in the epithelial region. Prognostically, no significant association was observed between MRPL13 expression and overall survival, regardless of epithelial or stromal section. Through these pan-SCC analyses, we have expanded the understanding of MRPL13 previously reported, in particular, underscoring the immunological involvement of MRPL13 in the tumor microenvironment of SCC that has been under-recognized before, suggesting that MRPL13 may regulate the infiltration of CD8+ T cells into the SCC microenvironment.http://www.sciencedirect.com/science/article/pii/S2405844023107900MRPL13Pan-squamous cell carcinomaBioinformatics analysisPrognosticCD8+ T-cell infiltration
spellingShingle Yan Liang
Shuo He
Yiyi Tan
Qing Liu
Feng Zhao
Tao Liu
Conggai Huang
Xiaomei Lu
Shutao Zheng
In silico analyses of pan-squamous cell carcinoma unveiled the immunological implications of MRPL13, which had previously been under-recognized
Heliyon
MRPL13
Pan-squamous cell carcinoma
Bioinformatics analysis
Prognostic
CD8+ T-cell infiltration
title In silico analyses of pan-squamous cell carcinoma unveiled the immunological implications of MRPL13, which had previously been under-recognized
title_full In silico analyses of pan-squamous cell carcinoma unveiled the immunological implications of MRPL13, which had previously been under-recognized
title_fullStr In silico analyses of pan-squamous cell carcinoma unveiled the immunological implications of MRPL13, which had previously been under-recognized
title_full_unstemmed In silico analyses of pan-squamous cell carcinoma unveiled the immunological implications of MRPL13, which had previously been under-recognized
title_short In silico analyses of pan-squamous cell carcinoma unveiled the immunological implications of MRPL13, which had previously been under-recognized
title_sort in silico analyses of pan squamous cell carcinoma unveiled the immunological implications of mrpl13 which had previously been under recognized
topic MRPL13
Pan-squamous cell carcinoma
Bioinformatics analysis
Prognostic
CD8+ T-cell infiltration
url http://www.sciencedirect.com/science/article/pii/S2405844023107900
work_keys_str_mv AT yanliang insilicoanalysesofpansquamouscellcarcinomaunveiledtheimmunologicalimplicationsofmrpl13whichhadpreviouslybeenunderrecognized
AT shuohe insilicoanalysesofpansquamouscellcarcinomaunveiledtheimmunologicalimplicationsofmrpl13whichhadpreviouslybeenunderrecognized
AT yiyitan insilicoanalysesofpansquamouscellcarcinomaunveiledtheimmunologicalimplicationsofmrpl13whichhadpreviouslybeenunderrecognized
AT qingliu insilicoanalysesofpansquamouscellcarcinomaunveiledtheimmunologicalimplicationsofmrpl13whichhadpreviouslybeenunderrecognized
AT fengzhao insilicoanalysesofpansquamouscellcarcinomaunveiledtheimmunologicalimplicationsofmrpl13whichhadpreviouslybeenunderrecognized
AT taoliu insilicoanalysesofpansquamouscellcarcinomaunveiledtheimmunologicalimplicationsofmrpl13whichhadpreviouslybeenunderrecognized
AT conggaihuang insilicoanalysesofpansquamouscellcarcinomaunveiledtheimmunologicalimplicationsofmrpl13whichhadpreviouslybeenunderrecognized
AT xiaomeilu insilicoanalysesofpansquamouscellcarcinomaunveiledtheimmunologicalimplicationsofmrpl13whichhadpreviouslybeenunderrecognized
AT shutaozheng insilicoanalysesofpansquamouscellcarcinomaunveiledtheimmunologicalimplicationsofmrpl13whichhadpreviouslybeenunderrecognized